Dr. Van Oekelen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
281 1st Ave
New York, NY 10003Phone+1 212-420-2000- Is this information wrong?
Clinical Expertise
- Multiple myeloma
Education & Training
Icahn School of Medicine at Mount SinaiPhD, Biomedical Sciences, 2018 - 2022- KU Leuven UniversityMD, Medicine, summa cum laude, 2012 - 2016
- KU Leuven UniversityMSc, Bioinformatics, magna cum laude, 2012 - 2015
- KU Leuven UniversityBSc, Medicine, summa cum laude, 2009 - 2012
Awards, Honors, & Recognition
- Young Investigator Award International Myeloma Society, 2021
- Outstanding Abstract Award American Society of Hematology, 2021
Publications & Presentations
PubMed
- Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015-2020.Nicole Birrer, William Wesson, Edward R Scheffer Cliff, Aaron M Goodman, Al-Ola Abdallah, Rajshekhar Chakraborty, Vinay Prasad, Ghulam Rehman Mohyuddin, Oliver Van Oek...> ;Blood Cancer Journal. 2022 Nov 15
- 3 citationsMulti-Omics Profiling of the Tumor Microenvironment.Oliver Van Oekelen, Alessandro Laganà> ;Advances in Experimental Medicine and Biology. 2022 Jan 1
- CD8T cells: An ineffective armor against prolonged COVID-19 in cancer patients.Oliver Van Oekelen, Samir Parekh> ;Cell Reports. Medicine. 2022 Jul 19
- Join now to see all
Other Languages
- Dutch, French, German, Spanish
Hospital Affiliations
Mount Sinai Beth IsraelNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
